High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
Aim. To assess the long-term results of high-dose chemotherapy following autologous hematopoietic stem cell transplantation (autoHSCT) for multiple myeloma (MM) in the real setting and influence of different factors on the results. Materials and methods. From 2006 till 2018 in Pirogovs Center wer...
Guardado en:
Autores principales: | Nikita E. Mochkin, Vladislav O. Sarzhevskiy, Julia N. Dubinina, Elena G. Smirnova, Denis A. Fedorenko, Anna E. Bannikova, Dina S. Kolesnikova, Vladimir S. Bogatyrev, Anastasia A. Samoylova, Nikolay M. Faddeev, Vladimir Ya. Melnichenko |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71812a52bfeb4a50a069644ca48f8b9e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
por: Malkan Umit Yavuz, et al.
Publicado: (2021) -
Multiple myeloma
por: Larisa P. Mendeleeva, et al.
Publicado: (2021) -
Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis
por: Fei Gao, et al.
Publicado: (2021) -
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi R, et al.
Publicado: (2021) -
Case Report: Bortezomib Plus CDOP Followed by Sequential Autologous Hematopoietic Stem Cell Transplantation and Lenalidomide-Based Maintenance Therapy in Plasmablastic Lymphoma
por: Jiao Cai, et al.
Publicado: (2021)